Gregory D. Wasson
Known title: DirectorCIK: 0001188827
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
PIII appoints new Chief Clinical Officer. P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.
Transaction History
| OPRX | ▲ Buy | Grant | 34,517 | $0 | 6/9/2026 | View on chart |
| PIII | ▲ Buy | Grant | 2,000 | $0 | 8/6/2025 | View on chart |
| OPRX | ▲ Buy | Grant | 9,868 | $0 | 6/11/2025 | View on chart |
| OPRX | ▲ Buy | Grant | 13,286 | $0 | 6/7/2024 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 10,061 | $0 | 6/5/2024 | View on chart |
| PIII | ▲ Buy | Grant | 216,561 | $0 | 10/23/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 4,637 | $0 | 6/7/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 657 | $0 | 3/31/2023 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 409 | $0 | 12/30/2022 | View on chart |
| OPRX | ▲ Buy | Option Exercise | 334 | $0 | 9/29/2022 | View on chart |
| PIII | ▼ Sell | Other | 6,843,525 | — | 10/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk
OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.
OptimizeRx Expands Ad Reach via OpenPath Deal with The Trade Desk. OptimizeRx has announced a partnership with The Trade Desk that uses its OpenPath platform to add authenticated healthcare professional reach to the ad network. The deal is expected to broaden the company’s inventory and provide advertisers with more precise targeting in the healthcare space. This collaboration follows a series of moves to grow OptimizeRx’s presence in the digital advertising market.